Terumo (OTCMKTS:TRUMY) Shares Gap Down – Here’s What Happened

Terumo Corp. (OTCMKTS:TRUMYGet Free Report)’s share price gapped down prior to trading on Monday . The stock had previously closed at $14.68, but opened at $13.68. Terumo shares last traded at $13.68, with a volume of 234 shares trading hands.

Analysts Set New Price Targets

Separately, Nomura raised Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy”.

Check Out Our Latest Research Report on TRUMY

Terumo Price Performance

The stock has a 50-day moving average of $14.99 and a two-hundred day moving average of $14.04. The firm has a market cap of $21.03 billion, a price-to-earnings ratio of 20.08 and a beta of 0.68. The company has a current ratio of 2.19, a quick ratio of 1.37 and a debt-to-equity ratio of 0.13.

Terumo (OTCMKTS:TRUMYGet Free Report) last released its quarterly earnings results on Friday, August 7th. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.13. Terumo had a net margin of 13.83% and a return on equity of 10.44%. The business had revenue of $1.97 billion for the quarter, compared to analyst estimates of $1.84 billion. On average, analysts anticipate that Terumo Corp. will post 0.7 EPS for the current year.

About Terumo

(Get Free Report)

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other health care settings. Founded in 1921, the company has grown from producing clinical thermometers into a global provider of medical devices and related solutions.

Terumo’s businesses include cardiovascular and vascular intervention products, such as catheters, guidewires and other devices used in the treatment of heart and vascular conditions.

Recommended Stories

Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.